Runt-related transcription factor-1 ameliorates bile acid–induced hepatic inflammation in cholestasis through JAK/STAT3 signaling
Hepatology · 2023-06 · 77 (6) · 1866-1881
DOI: 10.1097/hep.0000000000000041 ↗Kurz gefasst
Fachartikel in der Zeitschrift Hepatology, online erschienen am 03.01.2023. Verfasst von Liangjun Zhang und 18 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Institute of Digestive Disease of PLA, Cholestatic Liver Diseases Center and Center for Metabolic Associated Fatty Li…. Hauptthemen laut MEDLINE: Bile Acids and Salts, Cholestasis, Inflammation. Die Arbeit wurde bisher 59-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIDDK NIH HHS.
Abstract (Originalsprache)
Background and Aims: Bile acids trigger a hepatic inflammatory response, causing cholestatic liver injury. Runt-related transcription factor-1 (RUNX1), primarily known as a master modulator in hematopoiesis, plays a pivotal role in mediating inflammatory responses. However, RUNX1 in hepatocytes is poorly characterized, and its role in cholestasis is unclear. Herein, we aimed to investigate the role of hepatic RUNX1 and its underlying mechanisms in cholestasis. Approach and Results: Hepatic expression of RUNX1 was examined in cholestatic patients and mouse models. Mice with liver-specific ablation of Runx1 were generated. Bile duct ligation and 1% cholic acid diet were used to induce cholestasis in mice. Primary mouse hepatocytes and the human hepatoma PLC/RPF/5- ASBT cell line were used for mechanistic studies. Hepatic RUNX1 mRNA and protein levels were markedly increased in cholestatic patients and mice. Liver-specific deletion of Runx1 aggravated inflammation and liver injury in cholestatic mice induced by bile duct ligation or 1% cholic acid feeding. Mechanistic studies indicated that elevated bile acids stimulated RUNX1 expression by activating the RUNX1 -P2 promoter through JAK/STAT3 signaling. Increased RUNX1 is directly bound to the promotor region of inflammatory chemokines, including CCL2 and CXCL2 , and transcriptionally repressed their expression in hepatocytes, leading to attenuation of liver inflammatory response. Blocking the JAK signaling or STAT3 phosphorylation completely abolished RUNX1 repression of bile acid–induced CCL2 and CXCL2 in hepatocytes. Conclusions: This study has gained initial evidence establishing the functional role of hepatocyte RUNX1 in alleviating liver inflammation during cholestasis through JAK/STAT3 signaling. Modulating hepatic RUNX1 activity could be a new therapeutic target for cholestasis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Gastroenterology, Institute of Digestive Disease of PLA, Cholestatic Liver Diseases Center and Center for Metabolic Associated Fatty Liver Disease, the First Affiliated Hospital (Southwest Hospital), Third…
- Institute of Digestive Diseases of PLA, Southwest Hospital, Third Military Medical University (Army Medical University), Chongqing, China.
- Cholestatic Liver Diseases Center and Center for Metabolic Associated Fatty Liver Disease, Southwest Hospital, Third Military Medical University (Army Medical University), Chongqing, China.
- Central South University School of Life Sciences, Changsha, Hunan Province, China.
- Queen Mary School, Nanchang University, Nanchang, Jiangxi Province, China.
- Medical Research Center, Southwest Hospital, Third Military Medical University (Army Medical University), Chongqing, China.
ORCID-Profile: Liangjun Zhang, Qiong Pan, Lu Zhang, Haihan Xia, Junwei Liao, Xiaoxun Zhang, Nan Zhao, Qiaoling Xie, Min Liao, Qiao Li, Ling Li, Shijun Fan, Jianwei Li, Shi-Ying Cai, James L Boyer, Jin Chai
Förderung
- NIDDK NIH HHS
Zitieren
APA
Zhang, L., Pan, Q., Zhang, L., Xia, H., Liao, J., Zhang, X., Zhao, N., Xie, Q., Liao, M., Tan, Y., Li, Q., Zhu, J., Li, L., Fan, S., Li, J., Zhang, C., Cai, S. Y., Boyer, J. L., & Chai, J. (2023). Runt-related transcription factor-1 ameliorates bile acid–induced hepatic inflammation in cholestasis through JAK/STAT3 signaling. Hepatology, 77(6), 1866-1881. https://doi.org/10.1097/hep.0000000000000041
Vancouver
Zhang L, Pan Q, Zhang L, Xia H, Liao J, Zhang X, et al. Runt-related transcription factor-1 ameliorates bile acid–induced hepatic inflammation in cholestasis through JAK/STAT3 signaling. Hepatology. 2023;77(6):1866-1881. doi:10.1097/hep.0000000000000041
BibTeX
@article{Zhang2023,
author = {Zhang, Liangjun and Pan, Qiong and Zhang, Lu and Xia, Haihan and Liao, Junwei and Zhang, Xiaoxun and Zhao, Nan and Xie, Qiaoling and Liao, Min and Tan, Ya and Li, Qiao and Zhu, Jinfei and Li, Ling and Fan, Shijun and Li, Jianwei and Zhang, Chengcheng and Cai, Shi-Ying and Boyer, James L and Chai, Jin},
title = {Runt-related transcription factor-1 ameliorates bile acid–induced hepatic inflammation in cholestasis through JAK/STAT3 signaling},
journal = {Hepatology},
year = {2023},
volume = {77},
number = {6},
pages = {1866--1881},
doi = {10.1097/hep.0000000000000041}
}
EUVIMED